Fibronectin fragments modulate monocyte VLA-5 expression and monocyte migration

Journal of Clinical Investigation

Volumn 104, Issue 4, 1999, Pages 419-430

  Trial, JoAnn ^a,b   Baughn, Robert E ^b   Wygant, James N ^c   McIntyre, Bradley W ^c   Birdsall, Holly H ^a,b,d   Youker, Keith A ^b,d   Evans, Alida ^b,d   Entman, Mark L ^b,d   Rossen, Roger D ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; SERINE PROTEINASE; VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL CELL; ARTICLE; CELL ADHESION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; ISCHEMIA; LYMPHOCYTE MIGRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REPERFUSION INJURY;

EID: 0032740990     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4824     Document Type: Article

References (57)

1. Cowan, M.J., Reichenbach, D., Turner, P. and Thostenson, C. 1991. Cellular response of the evolving myocardial infarction after therapeutic coronary artery reperfusion. Hum. Pathol. 22:154-163.
2. Rossen, R.D., and Mann, D.L. 1996. Myocardial inflammation. In Immunology: principles and practice. R.R. Rich, editor. C.V. Mosby and Co. St. Louis, MO. 1463-1481.
3. Boyle, M.P., and Weisman, H.F. 1993. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Circulation. 88:2872-2883.
4. Morita, M., Kawashima, S., Ueno, M., Kubota, A., and Iwasaki, T. 1993. Effects of late reperfusion on infarct expansion and infarct healing in conscious rats. Am. J. Pathol. 143:419-430.
5. Buckley, B.H., and Roberts, W.C. 1974. Steroid therapy during acute myocardial infarction: a cause of delayed healing and ventricular aneurysm. Am. J. Med. 56:244-250.
6. Roberts, R., DeMello, V., and Sobel, B.E. 1976. Deleterious effects of methyl-prednisolone in patients with myocardial infarction. Circulation. 53:(Suppl. 1):1204-1206.
7. Hammerman, H., Kloner, R.A., Hale, S., Schoen, F.J., and Braunwald, E. 1983. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation and ventricular function. Circulation. 68:446-452.
8. Hammerman, H., et al. 1983. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation. 67:1290-1295.
9. Sommers, H.M., and Jennings, R.B. 1964. Experimental acute myocardial infarction. Histologic and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery. Lab. Invest. 13:1491-1503.
10. Dreyer, W.J., et al. 1991. Neutrophil accumulation in ischemic canine myocardium. Circulation. 84:400-411.
11. Birdsall, H.H., et al. 1997. Complement CSa, TGFβ1 and MCP-1, in sequence, induce migration of monocytes into ischemic myocardium within the first 1 to 5 hours following reperfusion. Circulation. 95:684-692.
12. Weihrauch, D., Zimmermann, R., Arras, M., and Schaper, J. 1994. Expression of extracellular matrix proteins and the role of fibroblasts and macrophages in repair processes in ischemic porcine myocardium. Cell. Mol. Biol. Res. 40:105-116.
13. Weihrauch, D., Arras, M., Zimmermann, R., and Schaper, J. 1995. Importance of monocytes/macrophages and fibroblasts for healing of micronecroses in porcine myocardium. Mol. Cell. Biochem. 147:13-19.
14. Arras, M., et al. 1998. Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporin. Basic Res. Cardiol. 93:97-107.
15. Reuterdahl, C., Sundberg, C., Rubin, K., Funa, K., and Gerdin, B. 1993. Tissue localization of beta receptors for platelet derived growth factor and platelet derived growth factor B chain during wound repair in humans. J. Clin. Invest. 91:2065-2075.
16. Pierce, G.F., Mustoe, T.A., Altrock, B.W., Deuel, T.F., and Thomason, A. 1991. Role of platelet-derived growth factor in wound healing. J. Cell. Biochem. 45:319-326.
17. Pierce, G.F., et al. 1989. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J. Cell Biol. 109:429-440.
18. Pierce, G.F., Brown, D., and Mustoe, T.A. 1991. Quantitative analysis of inflammatory cell influx, procollagen type 1 synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta 1 therapy. J. Lab. Clin. Med. 117:373-382.
19. Cromack, D.T., Porras, R.B., and Mustoe, T.A. 1990. Current concepts in wound healing: growth factor and macrophage interaction. J. Trauma. 30(Suppl.):129-133.
20. Brown, E.J., and Goodwin, J.L. 1988. Fibronectin receptors of phagocytes. J. Exp. Med. 167:777-793.
21. Doherty, D.E., Henson, P.M., and Clark, R.A. 1990. Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration in the rabbit lung. J. Clin. Invest. 86:1065-1075.
22. Clemmensen, I., and Anderson, R.B. 1982. Different molecular forms of fibronectin in rheumatoid synovial fluid. Arthritis Rheum. 25:25-31.
23. Clark, R.A., Wikner, N.E., Doherty, D.E., and Morris, D.A. 1988. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. J. Biol. Chem. 263:12115-12123.
24. Yonemasu, K., Nakanishi, A., Sasaki, T., and Kashiba, S. 1983. Stimulation of locomotion of peripheral blood monocytes by human plasma fibronectin. Microbiol. Immunol. 27:283-290.
25. Yamada, K.M., and Kennedy, D.W. 1984. Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function. J. Biol. Chem. 99:29-36.
26. Michael, L.H., et al. 1985. Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion. Am. J. Physiol. 248:350-359.
27. Rossen, R.D., et al. 1988. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human Clq in vivo. Circ. Res. 62:572-584.
28. Dreyer, W.J., et al. 1989. Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium. Circ. Res. 65:1751-1762.
29. Zeng, L., Takeya, M., Ling, X., Nagasaki, A., and Takahashi, K. 1996. Interspecies reactivities of anti-human macrophage monoclonal antibodies to various animal species. J. Histochem. Cytochem. 44:845-853.
30. Zeng, L., Takeya, M., and Takahashi, K. 1996. AM-3K, a novel monoclonal antibody specific for tissue macrophages and its application to pathological investigation. J. Pathol. 178:207-214.
31. Youker, K.A., et al. 1994. Molecular evidence for induction of intercellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart. Circulation. 89:2736-2746.
32. Stouffer, G.A., et al. 1998. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and chrombin-induced proliferation of cultured smooth muscle cells. Circulation. 97:907-915.
33. Forsyth, K.D., and Levinsky, R.J. 1990. Preparative procedures of cooling and re-warming increase leukocyte integrin expression and function on neutrophils. J. Immunol. Methods. 128:159-163.
34. Birdsall, H.H., et al. 1997. Transendothelial migration of lymphocytes from HIV-1 infected donors. A mechanism for extravascular dissemination of HIV-1. J. Immunol. 158:5968-5977.
35. Baughn, R.E. 1986. Antibody-independent interactions of fibronectin, Clq, and human neutrophils with Treponema pallidum. Infect. Immun. 54:766-773.
36. Baughn, R.E., Demecs, M., Taber, L.H., and Musher, D.M. 1996. Epitope mapping of B-cell determinants on the 15-kilodalton lipoprotein of Treponema pallidum (Tpp15) with synthetic peptides. Infect. Immun. 64:2457-2466.
37. Keski-Oja J., Mosher, D.F. and Vaheri, A. 1977. Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem. Biophys. Res. Commun. 74:699-706.
38. Wright, S.D., and Meyer, C.B. 1985. Fibronectin receptor of human macrophages recognizes the sequence arg-gly-asp-ser. J. Exp. Med. 162:762-767.
39. Ruoslahti, E., and Hayman, E.G. 1979. Two active sites with different characteristics in fibronectin. FEBS Lett. 97:221-224.
40. Pierschbacher, M.D., Hayman, E.G., and Ruoslahti, E. 1982. Synthetic peptide with cell attachment activity of fibronectin. Proc. Natl. Acad. Sci. USA. 80:1224-1227.
41. Belkin, V.M., Kozlova, N.I., Bychkova, V.V., and Shekhonin, B.V. 1996. Beta 1 integrin subunit dimerization via disulfide bonds. Biochem. Mol. Biol. Int. 40:53-60.
42. Hormann, H., Richter, H., and Jelinic, V. 1987. The role of fibronectin fragments and cell-attached transamidase on the binding of soluble fibrin to macrophages. Thromb. Res. 46:39-50.
43. Ahumada, G.G., and Saffitz, J.E. 1984. Fibronectin in the rat heart: a link between cardiac myocytes and collagen. J. Histochem. Cytochem. 32:383-388.
44. Casscells, W., Kimura, H., Sanches, J.A., Yu, Z.-X., and Ferrans, V.J. 1990. Immunohistochemical study of fibronectin in experimental myocardial infarction. Am. J. Pathol. 137:801-810.
45. Shekhonin, B.V., Guriev, S.B., Irgashev, S.B., and Koteliansky, V.E. 1990. Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction. J. Mol. Cell. Cardiol. 22:533-541.
46. Kishimoto, T.K., Jutila, M.A., and Butcher, E.C. 1990. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc. Natl. Acad. Sci. USA. 87:2244-2248.
47. Moulder, K., Barton, A., and Weston, B. 1993. CD23-mediated homotypic cell adhesion: the role of proteolysis. Eur. J. Immunol. 23:2066-2071.
48. Itzhaky, D., Raz, N., and Hollander, N. 1998. The glycosylphosphatidylinositol-anchored form and the transmembrane form of CD58 are released from the cell surface upon antibody binding. Cell. Immunol. 187:151-157.
49. Jiang, Y., Zhu, J.F., Luscinskas, F.W., and Graves, D.T. 1994. MCP-1-stimulated monocyte attachment to laminin is mediated by beta 2-integrins. Am. J. Physiol. 267:1112-1118.
50. Pacifici, R., et al. 1994. Ligand binding to monocyte α5β1 integrin activates the α2β1 receptor via the α5 subunit cytoplasmic domain and protein kinase C.J. Immunol. 153:2222-2233.
51. Shaw, L.M., and Mercurio, A.M. 1994. Regulation of cellular interactions with laminin by integrin cytoplasmic domains: the A and B structural variants of the alpha 6 beta 1 integrin differentially modulate the adhesive strength, morphology, and migration of macrophages. Mol. Biol. Cell. 5:679-690.
52. Penberthy, T.W., Jiang, Y., Luscinskas, F.W., and Graves, D.T. 1995. MCP-1-stimulated monocytes preferentially utilize beta2-integrins to migrate on laminin and fibronectin. Am. J. Physiol. 269:60-68.
53. Yesner, L.M., Huh, H.Y., Pearce, S.F., and Silverstein, R.L. 1996. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 16:1019-1025.
54. Sugahara, H., et al. 1994. Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J. Exp. Med. 179:1757-1766.
55. Li, J., Brown, L.F., Laham, R.J., Volk, R., and Simons, M. 1997. Macrophage-dependent regulation of syndecan gene expression. Circ. Res. 81:785-796.
56. Kluge, A., et al. 1997. Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart. Cardiovasc. Res. 33:324-331.
57. Randolph, G.J., et al. 1998. A physiological function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. USA. 95:6924-6929.